The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Peripheral T-Cell Lymphomas (PTCL): Comprehensive Care

Heterogeneous mature T-cell neoplasms requiring tailored therapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Peripheral T-Cell Lymphomas (PTCL): Comprehensive Care?

PTCL accounts for about 10 to 15 percent of non-Hodgkin lymphomas in Western countries with higher prevalence in Asia.

Major subtypes include peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma (ALK-positive and ALK-negative) and extranodal NK/T-cell lymphoma.

Diagnosis combines lymph node or tissue biopsy, comprehensive immunophenotyping and molecular studies including T-cell receptor rearrangement.

Staging uses PET-CT, bone marrow biopsy and cerebrospinal fluid evaluation in selected subtypes.

Prognosis varies markedly by subtype with ALK-positive ALCL having favorable outcomes and others more aggressive.

Symptoms

Generalized lymphadenopathy with rapid growth in many subtypes.
B symptoms including fever, drenching night sweats and significant weight loss.
Skin involvement with rashes, plaques, tumors or erythroderma in cutaneous variants.
Hepatosplenomegaly, pleural effusion or ascites in extranodal disease.
Hemophagocytic syndrome with cytopenias and organ dysfunction may occur in aggressive cases.

Risk Factors

Older age with median diagnosis around 60 years for most subtypes.
Human T-lymphotropic virus type 1 in adult T-cell leukemia/lymphoma.
Epstein-Barr virus in extranodal NK/T-cell lymphoma and angioimmunoblastic disease.
Celiac disease for enteropathy-associated T-cell lymphoma.
Immunosuppression following organ transplantation increases risk of certain subtypes.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Rapidly enlarging lymph nodes, persistent unexplained fever or significant weight loss requires urgent evaluation.
  • Extensive skin lesions, refractory rash or new tumor formation needs dermatology and hematology assessment.
  • Severe abdominal pain, gastrointestinal bleeding or symptoms of bowel obstruction warrant immediate workup.
  • Cytopenias, fevers and organ dysfunction during treatment may signal hemophagocytic syndrome and need critical care.
  • Long-term follow-up monitors for relapse, secondary malignancies and treatment-related cardiac, endocrine or neurologic effects.

Treatment Methods

01
Anthracycline-based regimens such as CHOP or CHOEP are commonly used as first-line therapy in most aggressive subtypes.
02
Brentuximab vedotin combined with CHP is the standard for CD30-positive systemic anaplastic large cell lymphoma.
03
Romidepsin, pralatrexate, belinostat and chidamide are options in relapsed or refractory disease.
04
Autologous stem cell transplantation is considered in first remission for high-risk subtypes; allogeneic transplant for selected relapsed cases.
05
Special protocols including SMILE or DDGP are used for extranodal NK/T-cell lymphoma; subtype-specific clinical trials and supportive care including infection prophylaxis are essential.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.